Trial site
Ascension via Christi Research
- 7running trials
- 4closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease5 trials
- Crohn's disease1 trial
- Depression1 trial
- Familial hypercholesterolaemia1 trial
- Migraine1 trial
- Mild cognitive impairment1 trial
- Schizophrenia1 trial
- Stroke1 trial
- Phase
- Phase 38 trials
- Phase 22 trials
- Phase 41 trial
- Status
- Active, not recruiting6 trials
- Completed3 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Janssen Research & Development, LLC3 trials
- Cassava Sciences, Inc.2 trials
- Eli Lilly and Company2 trials
- Annovis Bio Inc.1 trial
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company1 trial
- and 2 more
Running trials
Recruiting
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
Active, not recruiting
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease1 recruiting
Closed trials
Terminated
Open-label Extension for Phase 3 Clinical Trials of Simufilam
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026